-+ 0.00%
-+ 0.00%
-+ 0.00%

Exagen Reports Validation, Regulatory Submission For Approval Of New Systemic Lupus Erythematosus And Rheumatoid Arthritis Biomarkers, To Be Incorporated Into AVISE CTD Platform

Benzinga·11/14/2024 21:32:50
Listen to the news

Collectively, these new biomarkers will further improve the clinical utility of AVISE CTD, providing clinicians with the information they need to definitively diagnose patients and shorten their autoimmune diagnostic journeys.